Parenting in the genomic age: The 'cursed blessing' of newborn screening

New Genetics and Society

Volumn 25, Issue 2, 2006, Pages 159-170

  Grob, Rachel ^a  

^a SARAH LAWRENCE COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILD PARENT RELATION; GENETIC DISORDER; GENOMICS; HUMAN; NEWBORN SCREENING; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 33748551013     PISSN: 14636778     EISSN: 14699915     Source Type: Journal    
DOI: 10.1080/14636770600855218     Document Type: Review

References (31)

1. American Academy of Pediatrics (AAP) (2000) Serving the family from birth to the medical home. Newborn screening: a blueprint for the future. A call for a national agenda on state newborn screening programs, Pediatrics, 106(2), pp. 389-427.
2. ACMG (American College of Medical Genetics) (2005) Newborn Screening: Toward a Uniform Screening Panel and System (Federal Register).
3. Al-Jader, L.N. et al. (1990) Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis, Clinical Genetics, 38, pp. 460-5.
4. Annas, G.J. (1982) Mandatory PKU screening: the other side of the looking glass, American Journal of Public Health, 72, pp. 137-60.
5. Bates, B. (2003) Prenatal screening halves CF births, ObGyn News (Online), 38(24), available from www.obgyn.net/ (accessed June 2005).
6. Boland, C. & Thompson, N.L. (1990) Effect of newborn screening of cystic fibrosis on reported maternal behaviour, Archives of Disease in Childhood, 65(11), pp. 1240-4.
7. Centers for Disease Control and Prevention (2004) Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs, MMWR, No. RR-13.
8. Ciske, D.J. et al. (2001) Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process, Pediatrics, 107(4), pp. 699-706.
9. Clayton, E.W. (1992a) Symposium: legal and ethical issues raised by human genome project, screening and treatment of newborns, Houston Law Review, 29, pp. 85-148.
10. Clayton, E.W. (1992b) Issues in state newborn screening programs, Pediatrics, 90, pp. 641-6.
11. Curtin, S. & Park, M. (1999) Trends in the attendant, place, and timing of the births, and in the use of obstetric interventions: United States, 1989-97, National Vital Statistics Report, Centers for Disease Control and Prevention, 47(27), pp. 1-12.
12. Dankert-Roelse, J.T. et al. (1987) Effect of screening for cystic fibrosis on the influence of genetic counseling, Clinical Genetics, 32, pp. 271-272-275.
13. Downie, J. & Wildeman, S. (2001) Genetic and metabolic screening of newborns: must health care providers seek explicit parental consent?, Health Law Journal, 9, pp. 61-100.
14. Faden, R. et al. (1982) A survey to evaluate parental consent as public policy for neonatal screening, American Journal of Public Health, 72, pp. 1347-52.
15. GAO (General Accounting Office) (2003) Newborn Screening: Characteristics of State Programs (Washington, DC: United States General Accounting Office).
16. Hiller, E. et al. (1997) Public participation in medical policy-making and the status of consumer autonomy: the example of newborn-screening programs in the United States, American Journal of Public Health, 87(8), pp. 1280-9.
17. Hoff, T. & Hoyt, A. (2006) Practices and perceptions of long-term follow-up among state newborn screening programs, Pediatrics, 117(6), pp. 1922-9.
18. Holtzman, N. et al. (1983) Effect of informed parental consent on mothers' knowledge of newborn screening, Pediatrics, 72(6), pp. 807-12.
19. Knoppers, B.M. (1994) Newborn screening and informed consent, International Congress Series, 1041, pp. 15-24.
20. Lupton, D. (1995) The Imperative of Health: Public Health and the Regulated Body (London: Sage Publications).
21. Mischler, E. et al. (1998) Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling, Pediatrics, 102(1), pp. 44-53.
22. Nelkin, D. (1996) The social dynamics of genetic testing: the case of fragile X, Medical Anthropology Quarterly, 10, pp. 537-50.
23. Norton, J.P. (1906) The economic advisability of inaugurating a national organization of health, Journal of the American Medical Association, XLVII(2).
24. Rosner, J. (2004) Lullabies for Sophia, Hastings Center Report, 34(6), pp. 20-1.
25. Rothman, B.K. (1986) The Tentative Pregnancy (New York: Viking).
26. Shakespeare, T. (1995) Back to the future? New genetics and disabled people, Critical Social Policy, pp. 22-35.
27. Therell, B. (2001) U.S. newborn screening policy dilemmas for the twenty-first century, Molecular Genetics and Metabolism, 74(1-2), pp. 64-74.
28. Tluczek, A. et al. (1992) Parents' knowledge of neonatal screening and response to false-positive cystic fibrosis testing, Journal of Developmental and Behavioral Pediatrics, 13(3), pp. 181-6.
29. Waisbren, S.E. et al. (2003) Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress, American Medical Association, 290(19), pp. 2564-74.
30. Wertz, D.C. et al. (1992) Attitudes toward the prenatal diagnosis of cystic fibrosis: factors in decision making among affected families, American Journal of Human Genetics, 50, pp. 1077-85.
31. Wright, L. et al. (1992) Newborn screening: the miracle and the challenge, Journal of Pediatric Nursing, 7, pp. 26-42.